undamentalytics Newsletter
Sign in

Ihuman Inc. (IH) stock

Add to watchlist

Add holding +

NYSE: IH NYSE Education Services

C+ Fundamentals grade

Ihuman Inc. is a US-listed company in the education services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: our cash-flow value ($6.65) was left out of our combined valuation (it is 5.83x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating.

Price vs value

Under review: our cash-flow value ($6.65) was left out of our combined valuation (it is 5.83x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating. We'll show the comparison once resolved.

Ihuman Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds5 adding, 2 cuttingOf 1 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Ihuman files

Where Ihuman stands after its latest Filing

Revenue for the twelve months was $112m, down 12.4% on a year earlier, a steeper fall than the 10.9% decline a quarter earlier. That puts it 22 of 25 for growth among the education services companies we cover. Free-cash-flow margin rose to 5.8% from 0.6% a year earlier. Operating margin widened to 8.3% from -5.7%. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 2 of our 2 financial-health checks.

Our model value for Ihuman is under review, so past values are not shown until it is resolved.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Ihuman Inc.'s trailing-twelve-month revenue fell 12.4% year on year, with a free-cash-flow margin of 5.8%. Where it stands out: stock pay as % of revenue of 0.1% ranks 1 of 21 education services companies we cover. Where it lags: revenue growth of -12.4% ranks 22 of 25 education services companies we cover.

Our discounted-cash-flow model values the business at ~$6.7 per share in the base case (~$5.8–$7.8 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Revenue growth decelerating: TTM revenue growth slowed to -12.4% (-1.5pp vs the prior quarter), the 5th consecutive quarterly slowdown.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 1.3% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.2bn.

Things to watch

  • Revenue shrinking. Revenue fell 12.4% over the last 12 months.
  • Weak cash conversion. Free cash flow was 49% of net income over the last 12 months.

Price chart

  • 1 day0.0%
  • 1 week0.0%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$112M
Operating margin
8.3%
Net margin
11.8%
EPS (TTM, diluted)
$0.25

Growth

Revenue growth
−12.4%
Change in growth rate
−1.5 pts
Share count change
−1.3%

Cash

Free cash flow (TTM)
$6.5M
FCF margin
5.8%
Stock pay % of revenue
0.1%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for IH from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Ihuman Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: our cash-flow value ($6.65) was left out of our combined valuation (it is 5.83x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating.

Our value per share comes from a discounted-cash-flow model of Ihuman Inc.'s free cash flow after stock-based pay ( $10.3M, FY2025 Q4 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Ihuman Inc. as an operating company, with every model that fits that kind of business. Cost of equity 8.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.8 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$6.7 ~$5.8–$7.8 Left out: out of range vs price (5.64x)
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$0.7 ~$2.6–$4.0 Left out: far from the other models (more than 3x away from their median)
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$3.3 ~$2.2–$4.9 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$3.4 ~$2.9–$4.2 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Ihuman Inc. with Education Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Ihuman Inc.: too few analysts cover it.

Positioning

Short interest
0.0%
of tradable shares
Days to cover
0.13
at average volume
Short interest, 1 month
−44%
to October 15, 2026
Held by institutions
1%
of shares
Held by insiders
0.0%
of shares
Employees
558
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Ihuman Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Ihuman Inc.
$0 $50M $100M $150M FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 Revenue (TTM), FY18 Q4: $20M Revenue (TTM), FY19 Q4: $31.7M Revenue (TTM), FY20 Q4: $77.1M Revenue (TTM), FY21 Q4: $146.5M Revenue (TTM), FY22 Q4: $146.8M Revenue (TTM), FY23 Q4: $143.9M Revenue (TTM), FY24 Q4: $128.2M Revenue (TTM), FY25 Q4: $112.3M $112.3M

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue (TTM)
FY18 Q4 $20M
FY19 Q4 $31.7M
FY20 Q4 $77.1M
FY21 Q4 $146.5M
FY22 Q4 $146.8M
FY23 Q4 $143.9M
FY24 Q4 $128.2M
FY25 Q4 $112.3M
Revenue growth, TTM YoY Ihuman Inc.
-50% 0% 50% 100% 150% FY19 Q4 FY21 Q4 FY23 Q4 FY25 Q4 Revenue growth, TTM YoY, FY19 Q4: 58.5% Revenue growth, TTM YoY, FY20 Q4: 143.5% Revenue growth, TTM YoY, FY21 Q4: 90.0% Revenue growth, TTM YoY, FY22 Q4: 0.2% Revenue growth, TTM YoY, FY23 Q4: -2.0% Revenue growth, TTM YoY, FY24 Q4: -10.9% Revenue growth, TTM YoY, FY25 Q4: -12.4% -12.4%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue growth, TTM YoY
FY19 Q4 58.5%
FY20 Q4 143.5%
FY21 Q4 90.0%
FY22 Q4 0.2%
FY23 Q4 -2.0%
FY24 Q4 -10.9%
FY25 Q4 -12.4%
Operating margin (TTM) Ihuman Inc.
-150% -100% -50% 0% 50% FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 Operating margin (TTM), FY18 Q4: -16.7% Operating margin (TTM), FY19 Q4: -127.5% Operating margin (TTM), FY20 Q4: -8.4% Operating margin (TTM), FY21 Q4: -5.7% Operating margin (TTM), FY22 Q4: 11.3% Operating margin (TTM), FY23 Q4: 15.7% Operating margin (TTM), FY24 Q4: 7.8% Operating margin (TTM), FY25 Q4: 8.3% 8.3%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Operating margin (TTM)
FY18 Q4 -16.7%
FY19 Q4 -127.5%
FY20 Q4 -8.4%
FY21 Q4 -5.7%
FY22 Q4 11.3%
FY23 Q4 15.7%
FY24 Q4 7.8%
FY25 Q4 8.3%
FCF margin (TTM) Ihuman Inc.
-20% 0% 20% 40% FY18 Q4 FY20 Q4 FY22 Q4 FY25 Q4 FCF margin (TTM), FY18 Q4: -3.8% FCF margin (TTM), FY19 Q4: 18.4% FCF margin (TTM), FY20 Q4: 38.9% FCF margin (TTM), FY21 Q4: 0.6% FCF margin (TTM), FY22 Q4: 18.5% FCF margin (TTM), FY23 Q4: 16.3% FCF margin (TTM), FY24 Q4: 5.5% FCF margin (TTM), FY25 Q4: 5.8% 5.8%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period FCF margin (TTM)
FY18 Q4 -3.8%
FY19 Q4 18.4%
FY20 Q4 38.9%
FY21 Q4 0.6%
FY22 Q4 18.5%
FY23 Q4 16.3%
FY24 Q4 5.5%
FY25 Q4 5.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Ihuman took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $112M
  2. Other income $4.9M · 4.3%
  3. Cost of revenue $36.1M · 32.1%
  4. Gross profit $76.2M · 67.9%
  5. Research and development $29M · 25.8%
  6. Selling, general and admin $37.9M · 33.8%
  7. Operating income $9.3M · 8.3%
  8. Income tax $888,732 · 0.8%
  9. Net income $13.3M · 11.8%

Shares of revenue. Source: Ihuman's 10-K for FY2025, as filed with the SEC. Other income is income outside operations, such as investment gains.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 20 32 77 146 147 144 128 112
Gross profit 10 19 53 102 103 102 89 76
EBITDA −3 −40 −6 −7 18 24 12 10
Operating income −3 −40 −6 −8 17 23 10 9
Net income −3 −40 −5 −6 16 26 14 13
Diluted EPS −$0.08 −$1.10 — −$0.11 $0.31 $0.47 $0.25 $0.25
Growth (year on year)
Revenue — +58.5% +143.5% +90.0% +0.2% −2.0% −10.9% −12.4%
EBITDA — — — — — +33.0% −51.0% −12.8%
Operating income — — — — — +36.0% −55.8% −7.1%
Net income — — — — — +56.3% −46.4% −3.1%
Diluted EPS — — — — — +52.8% −46.4% +0.1%
Margins
Gross margin 50.1% 61.5% 68.7% 69.9% 70.1% 70.8% 69.4% 67.9%
EBITDA margin −16.5% −127.2% −7.8% −5.1% 12.4% 16.9% 9.3% 9.2%
Operating margin −16.7% −127.5% −8.4% −5.7% 11.3% 15.7% 7.8% 8.3%
Net margin −13.3% −126.0% −7.0% −3.9% 11.1% 17.8% 10.7% 11.8%
Free-cash-flow margin −3.8% 18.4% 38.9% 0.6% 18.5% 16.3% 5.5% 5.8%
Cash flow
Cash from operations −1 6 32 6 28 24 8 7
Capital spending 0 0 2 5 1 1 1 1
Free cash flow −1 6 30 1 27 23 7 6
Stock-based pay — 39 12 2 2 1 0 0
Free cash flow after stock pay — −33 18 −1 25 22 7 6
Balance sheet
Cash 1 15 132 134 152 171 154 165
Total debt 0 0 0 0 0 0 0 0
Net debt (negative = net cash) −1 −15 −132 −134 −152 −171 −154 −165
Diluted shares 32m 36m 45m 53m 54m 55m 54m 54m
Returned to shareholders
Dividends — — — — — — 5 5
Buybacks — — — 0 1 1 1 2
Total returned — — — 0 1 1 6 8

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · December 31, 2025
What it owns · $196m
Short-term assets $186mLonger-term assets $10m
What it owes, and who funded it · $196m
Short-term liabilities $52mLonger-term liabilities $1mShareholders' equity $142m
  • Short-term assets cover short-term liabilities $186m of assets due within a year against $52m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $186m short-term assets against $1m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Ihuman Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2025 Q4 TTM
Buybacks (TTM)
$2.4M
Dividends (TTM)
$5.4M
Returned to shareholders
121%
of free cash flow
Buybacks, last 3 fiscal years
$5.1M
Diluted share count
−1.3%
year over year
Total shareholder yield
12.4%
dividends 8.6% + buybacks 3.8% of market value
Dividend payout ratio
41%
of net income paid out
R&D spending
25.8%
of revenue
Days sales outstanding
22 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in education services
Last 12 months unless stated IH COE LGCY NRDY YOUL CHGG Median
Revenue, last 12 months $112m $96m $80m $178m $258m $266m $266m
Revenue growth, last 12 months −12.4% 88.6% 24.8% −0.2% 17.1% −47.6% 7.5%
Revenue growth, 3-year average — — — 1.3% — −29.0% 10.3%
Revenue growth, latest quarter — — 12.0% −4.5% — −50.7% 5.8%
Gross margin 67.9% 73.9% — 61.0% 10.4% 58.0% 54.6%
Operating margin 8.3% −15.1% 14.8% −25.4% 0.4% −20.9% 5.0%
Operating margin, 3-year average — −221.7% 14.6% −32.4% — −53.7% 5.9%
Net margin 11.8% −17.6% 11.4% −17.0% 2.3% −20.0% 3.9%
Cash from operations / revenue 6.4% 12.4% 5.0% −6.7% 0.6% 3.8% 8.4%
Free-cash-flow margin 5.8% 10.0% 3.3% −9.9% 0.6% −2.6% 5.8%
Free-cash-flow margin, 3-year average — <−999% 5.6% −12.8% — 5.3% 5.4%
Stock pay / revenue 0.1% 1.4% 1.5% 12.6% — 6.7% 1.4%
Change in share count −1.3% 2.3% 9.9% 6.0% 4.1% 5.0% 0.7%

Median of all 25 companies we cover in education services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

25 education services companies
Measure Company Peer median Rank
Revenue growth Growth -12.4% 7.5% 22 of 25
Change in growth rate Growth -1.5pp -0.5pp 15 of 25
Gross margin Profitability 67.9% 54.6% 2 of 19
Operating margin Profitability 8.3% 5.0% 11 of 25
Net margin Profitability 11.8% 3.9% 8 of 25
Free-cash-flow margin Cash generation 5.8% 5.8% 13 of 25
Stock pay as % of revenue Cash generation 0.1% 1.4% 1 of 21
Change in share count Balance sheet -1.3% 0.7% 10 of 24
Days sales outstanding Balance sheet 22 days 29 days 8 of 18

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$180,482
Institutions reporting
8
Shares held vs prior quarter
▲ 18.8%
Positions opened / closed
2 / 1

Top buyers and sellers, Q2 2026: 5 institutions bought and 2 sold ; the biggest buyer was Goldman Sachs Group Inc (+13K shares) and the biggest seller Morgan Stanley (−16K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Morgan Stanley $53,219 38K 29.5% ▼ 29.9%
Citadel Advisors LLC $45,781 33K 25.4% ▲ 30.6%
Susquehanna International Group, LLP $23,731 17K 13.1% ▲ 65.9%
Acadian Asset Management LLC $20,000 15K 11.1% 0.0%
Goldman Sachs Group Inc $17,683 13K 9.8% New
Credit Agricole S A $14,005 10K 7.8% New
BNP Paribas Financial Markets $5,882 4K 3.3% 0.0%
UBS Group AG $181 0K 0.1% ▲ 30.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ihuman Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Ihuman Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Ihuman Inc. in brief

What does Ihuman Inc. do?
Ihuman Inc. is a US-listed company in the education services industry. Its financial year ends in December.
What is Ihuman Inc.'s stock ticker?
Ihuman Inc. trades under the ticker IH on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Ihuman Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Ihuman Inc. reported revenue of $112M, 12.4% lower than a year earlier, according to its SEC filings.
What is Ihuman Inc.'s free cash flow?
Ihuman Inc.'s free-cash-flow margin is 5.8% of revenue over the trailing twelve months, ranking 13 of the 25 education services companies we cover.
Who are Ihuman Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Morgan Stanley, Citadel Advisors LLC and Susquehanna International Group, LLP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Ihuman Inc. buying back stock, and does it pay a dividend?
Ihuman Inc. spent $2.4M on share repurchases over the trailing twelve months, and its diluted share count fell 1.3% over the year.
Does Ihuman Inc. pay a dividend?
Yes: Ihuman Inc. paid $5.4M in dividends over the trailing twelve months, a dividend yield of 8.61% and a payout ratio of 41.0%.
Who are Ihuman Inc.'s competitors?
In our Education Services peer group, the companies closest to Ihuman Inc. are 51talk Online Education Group, Legacy Education Inc., Nerdy Inc., Youlife Group Inc. and Chegg, Inc. The side-by-side comparison below sets their revenue, margins and growth against Ihuman Inc.'s.